These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of anticoagulants on the activity of gelatinases. Castellazzi M, Tamborino C, Fainardi E, Manfrinato MC, Granieri E, Dallocchio F, Bellini T. Clin Biochem; 2007 Nov; 40(16-17):1272-6. PubMed ID: 17904541 [Abstract] [Full Text] [Related]
4. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Mannello F, Tanus-Santos JE, Meschiari CA, Tonti GA. Anal Biochem; 2008 Mar 01; 374(1):56-63. PubMed ID: 18082127 [Abstract] [Full Text] [Related]
5. Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Souza-Tarla CD, Uzuelli JA, Machado AA, Gerlach RF, Tanus-Santos JE. Clin Biochem; 2005 May 01; 38(5):410-4. PubMed ID: 15820769 [Abstract] [Full Text] [Related]
6. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Gerlach RF, Demacq C, Jung K, Tanus-Santos JE. Clin Biochem; 2007 Jan 01; 40(1-2):119-23. PubMed ID: 17150202 [Abstract] [Full Text] [Related]
10. Concentrations of circulating gelatinases (matrix metalloproteinase-2 and -9) are dependent on the conditions of blood collection. Meisser A, Cohen M, Bischof P. Clin Chem; 2005 Jan 01; 51(1):274-6. PubMed ID: 15613733 [No Abstract] [Full Text] [Related]
12. [Comparative studies with various anticoagulant stabilizer combinations for the preservation of blood specimen in leukosis diagnosis. 1. Studies on storage life of dry-preserved blood vials for the hematologic diagnosis of leukosis]. Beier D, Anders A, Mieth K. Arch Exp Veterinarmed; 1975 Jan 01; 29(1):143-6. PubMed ID: 812447 [Abstract] [Full Text] [Related]
17. Low molecular weight heparin treatment decreases MMP-9 plasma activity in patients with abdominal aortic aneurysm. Grzela T, Brawura-Biskupski-Samaha R, Jelenska MM, Szmidt J. Eur J Vasc Endovasc Surg; 2008 Feb 01; 35(2):159-61. PubMed ID: 17964826 [Abstract] [Full Text] [Related]
18. [Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease]. Kwon OS, Lim DY, Kwon KA, Chung MG, Park DK, Kim SS, Kim YS, Kwon SY, Koo YS, Kim YK, Choi DJ, Kim JH, Hwang YJ, Byun KS, Lee CH. Taehan Kan Hakhoe Chi; 2003 Sep 01; 9(3):222-30. PubMed ID: 14515040 [Abstract] [Full Text] [Related]
19. Effects of blood collection methods on gelatin zymography of matrix metalloproteinases. Mannello F. Clin Chem; 2003 Feb 01; 49(2):339-40. PubMed ID: 12560371 [No Abstract] [Full Text] [Related]
20. [Effects of heparin on the growth, extracellular matrix and matrix metalloproteinase gene expression in rat hepatic stellate cells]. Li W, Zhang J, Huang G, Zhu H, Zhang X, Zhang Y. Zhonghua Gan Zang Bing Za Zhi; 2000 Aug 01; 8(4):200-2. PubMed ID: 10951616 [Abstract] [Full Text] [Related] Page: [Next] [New Search]